SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
A man prepares the daily pills his wife will need for the week on January 4, 2020 in Sarasota, Florida. (Photo: Andrew Lichtenstein/Corbis via Getty Images)
Seniors Would Cross Party Lines to Back Candidates Who Support Medicare Negotiating Drug Prices: Poll
"This poll confirms that high drug prices are a top-of-mind issue for seniors when making voting decisions."
Aug 03, 2021
A survey released Tuesday by the Alliance for Retired Americans finds that seniors overwhelmingly support allowing Medicare to negotiate prescription drug prices directly with pharmaceutical companies--so much so that a sizeable percentage would cross party lines to vote for a candidate who backs the proposed reform.
"Even in today's polarized political environment, a significant percentage of senior voters of both parties would cross party lines over this issue."
--Richard Fiesta, Alliance for Retired Americans
Conducted by the firm Lake Research Partners, the new poll (pdf) shows that 87% of voters over the age of 65--including 89% of Democrats, 87% of Republicans, and 81% of independents--support allowing Medicare to negotiate drug prices, which it is currently barred from doing under federal law.
The survey also found that 31% of Republican seniors would be more likely to vote for a Democrat who supports ongoing congressional efforts to allow Medicare to negotiate drug prices, indicating a substantial political upside for candidates who back the idea--which would lower federal spending by an estimated (pdf) $456 billion over ten years and potentially save patients thousands of dollars.
On the flip side, 55% of seniors said they would be less likely to support a Democratic candidate opposed to the popular reform, including 60% of Democratic seniors, 53% Republican seniors, and 49% of independent seniors.
Richard Fiesta, executive director of the Alliance for Retired Americans, said in a statement that the survey results "have major implications for both Democrats and Republicans in the 2022 midterm elections."
"Americans pay the highest prices in the world for prescription drugs, and they want lawmakers to take action now to lower the amount they pay at the pharmacy counter," said Fiesta. "This poll confirms that high drug prices are a top-of-mind issue for seniors when making voting decisions."
"The 2022 midterm electorate will have an outsized senior vote," he continued. "This poll highlights a risk and an opportunity for elected officials and candidates. Even in today's polarized political environment, a significant percentage of senior voters of both parties would cross party lines over this issue."
The survey came as Sen. Bernie Sanders (I-Vt.)--chair of the Senate Budget Committee--and other progressive lawmakers are pushing to include a Medicare drug-pricing provision in an emerging multitrillion-dollar reconciliation package. Senate Democratic leaders are reportedly aiming to include the provision--as well as an expansion of Medicare's benefits--in the legislation, but the details of the bill have yet to be finalized.
"It is time to end the international disgrace of Americans paying the highest prices in the world, by far, for prescription drugs," Sanders said Friday at a rally marking Medicare's 56th birthday.
Despite its popularity, the proposal is likely to run up against some opposition from Big Pharma-backed Democrats in the House. In a letter (pdf) to House Speaker Nancy Pelosi (D-Calif.) in May, a group of Democrats led by Reps. Scott Peters (D-Calif.) and Jake Auchincloss (D-Mass.) expressed opposition to H.R. 3, legislation that would empower Medicare to directly negotiate prices for a limited number of prescription drugs.
But other centrist Democrats--including some in so-called "frontline" districts at risk of flipping to the GOP in 2022--appear to have recognized the political benefits of supporting the proposal, which has broad bipartisan support across the U.S. population, not just among seniors.
In a letter (pdf) to Pelosi and Senate Majority Leader Chuck Schumer (D-N.Y.) last month, 15 House Democrats led by Rep. Susan Wild (D-Pa.) argued that "with public support of Medicare price negotiation of prescription drugs at nearly 90%, it is time to take action."
"Finally giving Medicare the power to negotiate drug prices to ensure that Americans are no longer price-gouged for life-saving medications is critical," the lawmakers wrote.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
A survey released Tuesday by the Alliance for Retired Americans finds that seniors overwhelmingly support allowing Medicare to negotiate prescription drug prices directly with pharmaceutical companies--so much so that a sizeable percentage would cross party lines to vote for a candidate who backs the proposed reform.
"Even in today's polarized political environment, a significant percentage of senior voters of both parties would cross party lines over this issue."
--Richard Fiesta, Alliance for Retired Americans
Conducted by the firm Lake Research Partners, the new poll (pdf) shows that 87% of voters over the age of 65--including 89% of Democrats, 87% of Republicans, and 81% of independents--support allowing Medicare to negotiate drug prices, which it is currently barred from doing under federal law.
The survey also found that 31% of Republican seniors would be more likely to vote for a Democrat who supports ongoing congressional efforts to allow Medicare to negotiate drug prices, indicating a substantial political upside for candidates who back the idea--which would lower federal spending by an estimated (pdf) $456 billion over ten years and potentially save patients thousands of dollars.
On the flip side, 55% of seniors said they would be less likely to support a Democratic candidate opposed to the popular reform, including 60% of Democratic seniors, 53% Republican seniors, and 49% of independent seniors.
Richard Fiesta, executive director of the Alliance for Retired Americans, said in a statement that the survey results "have major implications for both Democrats and Republicans in the 2022 midterm elections."
"Americans pay the highest prices in the world for prescription drugs, and they want lawmakers to take action now to lower the amount they pay at the pharmacy counter," said Fiesta. "This poll confirms that high drug prices are a top-of-mind issue for seniors when making voting decisions."
"The 2022 midterm electorate will have an outsized senior vote," he continued. "This poll highlights a risk and an opportunity for elected officials and candidates. Even in today's polarized political environment, a significant percentage of senior voters of both parties would cross party lines over this issue."
The survey came as Sen. Bernie Sanders (I-Vt.)--chair of the Senate Budget Committee--and other progressive lawmakers are pushing to include a Medicare drug-pricing provision in an emerging multitrillion-dollar reconciliation package. Senate Democratic leaders are reportedly aiming to include the provision--as well as an expansion of Medicare's benefits--in the legislation, but the details of the bill have yet to be finalized.
"It is time to end the international disgrace of Americans paying the highest prices in the world, by far, for prescription drugs," Sanders said Friday at a rally marking Medicare's 56th birthday.
Despite its popularity, the proposal is likely to run up against some opposition from Big Pharma-backed Democrats in the House. In a letter (pdf) to House Speaker Nancy Pelosi (D-Calif.) in May, a group of Democrats led by Reps. Scott Peters (D-Calif.) and Jake Auchincloss (D-Mass.) expressed opposition to H.R. 3, legislation that would empower Medicare to directly negotiate prices for a limited number of prescription drugs.
But other centrist Democrats--including some in so-called "frontline" districts at risk of flipping to the GOP in 2022--appear to have recognized the political benefits of supporting the proposal, which has broad bipartisan support across the U.S. population, not just among seniors.
In a letter (pdf) to Pelosi and Senate Majority Leader Chuck Schumer (D-N.Y.) last month, 15 House Democrats led by Rep. Susan Wild (D-Pa.) argued that "with public support of Medicare price negotiation of prescription drugs at nearly 90%, it is time to take action."
"Finally giving Medicare the power to negotiate drug prices to ensure that Americans are no longer price-gouged for life-saving medications is critical," the lawmakers wrote.
A survey released Tuesday by the Alliance for Retired Americans finds that seniors overwhelmingly support allowing Medicare to negotiate prescription drug prices directly with pharmaceutical companies--so much so that a sizeable percentage would cross party lines to vote for a candidate who backs the proposed reform.
"Even in today's polarized political environment, a significant percentage of senior voters of both parties would cross party lines over this issue."
--Richard Fiesta, Alliance for Retired Americans
Conducted by the firm Lake Research Partners, the new poll (pdf) shows that 87% of voters over the age of 65--including 89% of Democrats, 87% of Republicans, and 81% of independents--support allowing Medicare to negotiate drug prices, which it is currently barred from doing under federal law.
The survey also found that 31% of Republican seniors would be more likely to vote for a Democrat who supports ongoing congressional efforts to allow Medicare to negotiate drug prices, indicating a substantial political upside for candidates who back the idea--which would lower federal spending by an estimated (pdf) $456 billion over ten years and potentially save patients thousands of dollars.
On the flip side, 55% of seniors said they would be less likely to support a Democratic candidate opposed to the popular reform, including 60% of Democratic seniors, 53% Republican seniors, and 49% of independent seniors.
Richard Fiesta, executive director of the Alliance for Retired Americans, said in a statement that the survey results "have major implications for both Democrats and Republicans in the 2022 midterm elections."
"Americans pay the highest prices in the world for prescription drugs, and they want lawmakers to take action now to lower the amount they pay at the pharmacy counter," said Fiesta. "This poll confirms that high drug prices are a top-of-mind issue for seniors when making voting decisions."
"The 2022 midterm electorate will have an outsized senior vote," he continued. "This poll highlights a risk and an opportunity for elected officials and candidates. Even in today's polarized political environment, a significant percentage of senior voters of both parties would cross party lines over this issue."
The survey came as Sen. Bernie Sanders (I-Vt.)--chair of the Senate Budget Committee--and other progressive lawmakers are pushing to include a Medicare drug-pricing provision in an emerging multitrillion-dollar reconciliation package. Senate Democratic leaders are reportedly aiming to include the provision--as well as an expansion of Medicare's benefits--in the legislation, but the details of the bill have yet to be finalized.
"It is time to end the international disgrace of Americans paying the highest prices in the world, by far, for prescription drugs," Sanders said Friday at a rally marking Medicare's 56th birthday.
Despite its popularity, the proposal is likely to run up against some opposition from Big Pharma-backed Democrats in the House. In a letter (pdf) to House Speaker Nancy Pelosi (D-Calif.) in May, a group of Democrats led by Reps. Scott Peters (D-Calif.) and Jake Auchincloss (D-Mass.) expressed opposition to H.R. 3, legislation that would empower Medicare to directly negotiate prices for a limited number of prescription drugs.
But other centrist Democrats--including some in so-called "frontline" districts at risk of flipping to the GOP in 2022--appear to have recognized the political benefits of supporting the proposal, which has broad bipartisan support across the U.S. population, not just among seniors.
In a letter (pdf) to Pelosi and Senate Majority Leader Chuck Schumer (D-N.Y.) last month, 15 House Democrats led by Rep. Susan Wild (D-Pa.) argued that "with public support of Medicare price negotiation of prescription drugs at nearly 90%, it is time to take action."
"Finally giving Medicare the power to negotiate drug prices to ensure that Americans are no longer price-gouged for life-saving medications is critical," the lawmakers wrote.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.